Citi Pharma posts flat 9MFY25 profit at nearly Rs680m

News Image

MG News | April 30, 2025 at 04:46 PM GMT+05:00

0:00

April 30, 2025 (MLN): Citi Pharma Ltd. (PSX: CPHL) reported a net profit of Rs678.84 million for the nine months ended March 31, 2025, nearly unchanged from Rs681.40m in SPLY, reflecting a flat performance despite a decline in pre-tax earnings.

Earnings per share stood at Rs2.97, slightly down from Rs2.98 a year ago.

The company’s net sales rose 6% to Rs10.10 billion from Rs9.54bn, driven by increased demand and operational scale.

Cost of sales grew proportionately by 6% to Rs8.64bn, keeping gross profit growth at 8%, amounting to Rs1.46bn.

However, operating profit also rose 8% to Rs1.17bn despite higher selling expenses, which surged 19% to Rs119.70m.

Citi Pharma’s financial cost increased 15% to Rs231.51m, while other income sharply declined by 47% to Rs165.82m, reducing support to the bottom line. As a result, profit before income taxes and final tax fell by 8% to Rs1.03bn.

Taxation decreased by 20% year-on-year to Rs349.84m, helping offset some of the pressure on net profit.

Condensed interim statement of profit and loss for the nine month ended 31 March 2025 (in Rupees) 2025 2024 %Change
Sales - Net           10,100,185,059             9,535,266,706 6%
Cost of Sales            (8,643,865,934)            (8,192,103,683) 6%
Gross Profit             1,456,319,125             1,343,163,023 8%
Administrative Expenses                161,904,092                154,757,727 5%
Selling Expenses                119,703,970                100,497,146 19%
Operating Profit             1,174,711,063             1,087,908,150 8%
Financial (Cost) / Income               (231,505,104)               (200,800,962) 15%
Other Income/(Loss)                165,818,206                312,952,864 -47%
Other Expenses                 (80,335,099)                 (82,062,737) -2%
Profit before income taxes and final tax             1,028,689,066             1,117,997,315 -8%
Taxation - Final taxes                           (4,004)                       (255,970) -98%
Profit before income tax             1,028,685,062             1,117,741,345 -8%
Taxation - Income tax               (349,842,286)               (436,344,074) -20%
Profit after income tax                678,842,776                681,397,271 0%
Earnings per share (EPS) - Basic and Diluted 2.97 2.98  

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 148,617.78
624.60M
0.86%
1274.27
ALLSHR 91,685.08
1,340.28M
0.74%
669.39
KSE30 45,247.79
197.43M
0.83%
370.74
KMI30 212,370.79
224.51M
1.05%
2209.48
KMIALLSHR 61,227.89
711.87M
1.18%
715.56
BKTi 41,264.02
160.39M
0.54%
221.73
OGTi 30,019.10
23.63M
0.64%
190.41
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 108,265.00 0.00
0.00
-510.00
-0.47%
BRENT CRUDE 67.46 67.94
67.29
-0.52
-0.76%
RICHARDS BAY COAL MONTHLY 88.70 88.70
88.70
-0.75
-0.84%
ROTTERDAM COAL MONTHLY 96.15 96.75
96.00
-0.40
-0.41%
USD RBD PALM OLEIN 1,106.50 1,106.50
1,106.50
0.00
0.00%
CRUDE OIL - WTI 64.01 0.00
0.00
0.00
0.00%
SUGAR #11 WORLD 16.34 16.52
16.33
-0.14
-0.85%

Chart of the Day


Latest News
August 31, 2025 at 07:00 PM GMT+05:00

Weekly Market Roundup


August 30, 2025 at 04:28 PM GMT+05:00

Key Pakistan Market Stats and Economic Indicators


August 29, 2025 at 06:04 PM GMT+05:00

SCRA inflows offset Rs8.5bn net selling



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg